Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

December 13, 2018
Otsuka Medical Devices

Otsuka Medical Devices and Veryan Medical Announce Completion of Acquisition
December 11, 2018
Otsuka Pharmaceutical

Otsuka subsidiary Avanir and Optinose agree to terminate license agreement for migraine treatment ONZETRA®Xsail®
November 30, 2018
Otsuka Pharmaceutical

Otsuka and Lundbeck report positive phase II data for the combination treatment of brexpiprazole and sertraline for the treatment of Post-Traumatic Stress Disorder (PTSD)
November 7, 2018
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches a new REHADAYS to support exercise and rehabilitation, fruit mix flavor
October 31, 2018
Otsuka Pharmaceutical Factory

Lilium Otsuka launches a healthcare home appliance, “Lilium Spot”, which can easily check urine volume in the bladder
October 30, 2018
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory starts joint development of regenerative medicine products with Adipo Medical Technology
October 26, 2018
Taiho Pharmaceutical

FDA Accepts Supplemental New Drug Application for LONSURF® (trifluridine/tipiracil) for the Treatment of Metastatic Gastric/Gastroesophageal Junction (GEJ) Adenocarcinoma; Grants Priority Review
October 22, 2018
Taiho Pharmaceutical

Taiho and Servier Announce Positive Results from LONSURF® (trifluridine/tipiracil) Study Presented at ESMO 2018 Congress and Published in The Lancet Oncology
October 15, 2018
Otsuka Pharmaceutical

Quick Navi-Reader for Diagnosis of Influenza to be Launched in Japan
October 11, 2018
Otsuka Pharmaceutical

Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health
October 1, 2018
Taiho Pharmaceutical

Taiho Pharmaceutical Announces Change of Marketing Company for β-lactamase Inhibitor Combination Antibiotic ZOSYN®
October 1, 2018
Otsuka Pharmaceutical

Launch of Nationwide Retail Distribution of "Barrier Beverage" BODYMAINTÉ Drink
September 25, 2018
Otsuka Pharmaceutical

Busulfex Injection 60mg Approved in Japan for Once-Daily Administration in Adults
September 19, 2018
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory files patent infringement lawsuit against AY Pharmaceuticals and Yoshindo
September 13, 2018
Taiho Pharmaceutical

Taiho Pharmaceutical to Launch Zenol Diclodirect
September 12, 2018
Otsuka Holdings

Notice Regarding Company Split (Simplified Absorption–type Company Split)
September 11, 2018
Taiho Pharmaceutical

Taiho Pharmaceutical to Support the Pink Ribbon Campaign Again in 2018
September 6, 2018
Taiho Pharmaceutical

"Efil" Virus Removal/Antibacterial Spray to Go on Sale Nationwide on September 13, 2018
September 4, 2018
Otsuka Pharmaceutical Factory

Lilium Otsuka’s R&D project is selected for inclusion in FY 2018 Project to develop robotic devices for nursing care and set the standards (subsidized project for development) by AMED
September 3, 2018
Otsuka Pharmaceutical

Otsuka Pharmaceutical Cooperates with Community Health Promotion Efforts Tokushima Itano Factory Sponsors "Asan Walking Festa in Itano"
September 3, 2018
Otsuka Holdings

Otsuka Pharmaceutical Completes Acquisition of Visterra
August 21, 2018
Otsuka Pharmaceutical

Osaka University and Otsuka Pharmaceutical to Enter into an Executive Licensing Agreement on Novel "CAR-T Cell Therapy" for Multiple Myeloma
August 17, 2018
Taiho Pharmaceutical

Taiho Pharmaceutical Applies for Additional Indication of Gastric Cancer in Japan for its Anticancer agent LONSURF®
August 15, 2018
Otsuka Pharmaceutical

Otsuka Pharmaceutical Participates in Summer Events in Tokushima Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink PRESENTS Awa Odori Sound Festival
July 31, 2018
Otsuka Pharmaceutical

Otsuka and Lundbeck's Rxulti® (brexpiprazole) approved by the European Commission
July 31, 2018
Otsuka Pharmaceutical

Otsuka and Astex announce results of the phase 3 ASTRAL-1 study of guadecitabine (SGI-110) in treatment-naïve AML patients ineligible to receive intense induction chemotherapy
July 31, 2018
Otsuka Holdings

Notice concerning amendments to the forecasts (IFRS)
July 31, 2018
Otsuka Holdings

Otsuka and Lundbeck’s Rxulti® (brexpiprazole) approved by the European Commission
July 13, 2018
Taiho Pharmaceutical

Taiho Pharmaceutical Enters into Development of a Novel Immuno-Oncology Therapy with Arcus Biosciences
July 12, 2018
Otsuka Pharmaceutical

Focus on Core Temperature as a Heat Disorder Countermeasure - New POCARI SWEAT ICE SLURRY "Cools from the Core" -